Clinical Trials Directory

Trials / Completed

CompletedNCT02063477

Effect of Oligopin® on Blood Pressure.

Effect of a French Maritim Pine Bark Extract Oligopin® on Blood Pressure: Double Blind, Crossover, Placebo-controlled Nutrition Intervention Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Technological Centre of Nutrition and Health, Spain · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of the study is to evaluate the effect of consumption of a food supplement rich in procyanidins extracted from the bark of French pine, Oligopin®, on blood pressure of people with mild / moderate degree of hypertension. Furthermore, the effect Oligopin® consumption on markers involved in the development of hypertension, and endothelial function in key enzymes that regulate blood pressure, inflammation and oxidation are considered. Also, try to advance the understanding of the molecular mechanisms that regulate blood pressure.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboThe placebo composition is for 1 gelule: 250 mg maltodextrin + 30 mg magnesium stearate; total weight: 280 mg/gelule
DIETARY_SUPPLEMENTOligopin®Oligopin® PUR' expert (%) is a red brown powder extracted from the bark of the Maritime Pine (Pinus pinaster) with composition: \- TOTAL POLYPHENOL CONTENT \> 96 1. MONOMERS + PHENOLIC ACIDS 30 2. DIMERS \>15 3. OTHER OLIGOMERS 50 PROCYANIDINS CONTENT (GPC) \> 67 The Oligopin composition is for 1 gelule: 75 mg Oligopin + 175 mg maltodextrine + 30 mg magnesium stearate: total weight: 280 mg/gelule

Timeline

Start date
2014-02-01
Primary completion
2014-09-01
Completion
2014-10-01
First posted
2014-02-14
Last updated
2022-02-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02063477. Inclusion in this directory is not an endorsement.